Trials / Completed
CompletedNCT00251914
Nexium Dyspepsia/AST
Supportive Test for Acid-Related Symptoms (STARS I) With Esomeprazole and a Following 7-week, Double-blind, Randomized, Placebo Controlled Treatment Period in Subjects With Upper Gastrointestinal Symptoms and With Normal Findings at Esophagogastroduodenoscopy.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,500 (planned)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim is to evaluate if the resolution of upper abdominal symptoms (pain or burning) during an acid suppressive test trial of esomprazole given daily for 7 days predicts symptoms resolution at the end of a subsequent treatment period of 7 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole |
Timeline
- Start date
- 2002-12-01
- Primary completion
- 2005-01-01
- Completion
- 2005-01-01
- First posted
- 2005-11-11
- Last updated
- 2011-01-24
Locations
215 sites across 17 countries: Argentina, Belgium, Brazil, Canada, Denmark, France, Germany, Greece, Iceland, Italy, Norway, Romania, Singapore, South Africa, Spain, Sweden, Switzerland
Source: ClinicalTrials.gov record NCT00251914. Inclusion in this directory is not an endorsement.